BrierleyJ, ShermanE. The role of external beam radiation and targeted therapy in thyroid cancer. Semin Radiat Oncol, 2012; 22(3):254–262; doi: 10.1016/j.semradonc.2012.03.010
2.
ZhaoX, Rui WangJ, DaduR, et al. V600E mutant anaplastic thyroid cancer: A single center retrospective cohort study. Thyroid 2023;33(4):484–491.
3.
LeeM, UntchBR, XuB, et al.Genomic and transcriptomic correlates of thyroid carcinoma evolution after BRAF inhibitor therapy. Mol Cancer Res, 2022; 20(1):45–55; doi: 10.1158/1541-7786.MCR-21-0442
4.
SmallridgeRC, AinKB, AsaSL, et al.American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid, 2012; 22(11):1104–1139; doi: 10.1089/thy.2012.0302
5.
BibleKC, KebebewE, BrierleyJ, et al.2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer [published correction appears in Thyroid 2021;31(10):1606–1607]. Thyroid, 2021; 31(3):337–386; doi: 10.1089/thy.2020.0944
